SMAD3 and renal fibrosis: Liu L et al. proved that TAC upregulates NORAD to compete with miR-136-5p, resulting in a decrease in miR-136-5p expression, which in turn activates the TGF-β1/smad3 pathway, ultimately leading to the aggravation of renal fibrosis (30).